Search result

Phantom 4 RTK/feed/category/dji-matrice-30t-pl- Page 143

Ulta Beauty (ULTA) Stock Surges on Q3 2025 Beat and TD Cowen Upgrade – Is the Rally Just Getting Started?

Ulta Beauty (ULTA) Stock Surges on Q3 2025 Beat and TD Cowen Upgrade – Is the Rally Just Getting Started?

Ulta Beauty shares surged over 11% after posting Q3 net sales of $2.9 billion, up 12.9% year over year, and raising its full-year outlook. The stock traded near $610 on December 8, close to its 52-week high, and has gained about 42% year-to-date. Diluted EPS for the quarter reached $5.14, beating estimates. Management now expects fiscal 2025 net sales of $12.3 billion and EPS of $25.20–$25.50.
Semiconductor Stocks Today: AI Boom Lifts Chipmakers as Memory Shortage Deepens (Dec. 8, 2025)

Semiconductor Stocks Today: AI Boom Lifts Chipmakers as Memory Shortage Deepens (Dec. 8, 2025)

The PHLX Semiconductor Index rose 0.96% to 7,364.6 on Monday, near record highs, as chip stocks outpaced the broader market. Nvidia, Broadcom, AMD, and Micron all posted gains, with Micron up over 3% after an analyst upgrade. Fresh data showed a worsening global memory chip shortage and continued supply chain pressures. Investors focused on AI demand ahead of the Federal Reserve meeting.
Canada’s F‑35 Crossroads: Quebec Maintenance Hub, Leaked Scorecard and a Last‑Minute Gripen Push

Canada’s F‑35 Crossroads: Quebec Maintenance Hub, Leaked Scorecard and a Last‑Minute Gripen Push

A leaked Department of National Defence chart shows the F-35 scored 95% against the Swedish Gripen’s 33% in Canada’s fighter jet competition. L3Harris MAS is pushing to make Mirabel, Quebec a major F-35 maintenance hub, with plans to service over 2,000 jets if Canada commits to the full F-35 order. The project could cost $200 million and affect 5,000 jobs. Prime Minister Mark Carney is nearing a final decision.
8 Dezembro 2025
UK Stock Market Today: FTSE 100 Dips as Unilever Slumps on Magnum Spin‑Off (London Close, 8 December 2025)

UK Stock Market Today: FTSE 100 Dips as Unilever Slumps on Magnum Spin‑Off (London Close, 8 December 2025)

The FTSE 100 fell 0.2% to 9,645.09 on Monday as Unilever completed its ice cream spin-off and bond yields climbed. Magnum Ice Cream Company shares debuted in Amsterdam at €12.20, below the €12.80 reference price. UK government bonds dropped as traders scaled back rate-cut bets ahead of decisions from the Fed and Bank of England. The FTSE 250 lost 0.7%, while the AIM All-Share slipped 0.4%.
Eli Lilly (LLY) Stock After Hours on December 8, 2025: China Mounjaro Win, Dividend Hike and What to Watch Before Tuesday’s Open

Eli Lilly (LLY) Stock After Hours on December 8, 2025: China Mounjaro Win, Dividend Hike and What to Watch Before Tuesday’s Open

Eli Lilly shares closed at $998 on December 8, down 1.3%, marking a seventh straight decline and leaving the stock about 10% below its recent high. The company reported a 15% dividend increase, secured Chinese reimbursement for Mounjaro, and saw Nobel laureate Carolyn Bertozzi return to its board. Competition and price cuts in weight-loss drugs weighed on the stock.
Best Singapore Stocks to Buy Now (December 9, 2025): 8 SGX Picks for a Lower‑Rate World

Best Singapore Stocks to Buy Now (December 9, 2025): 8 SGX Picks for a Lower‑Rate World

Singapore’s Straits Times Index closed at 4,507.08 on Monday, just below record highs after a 19% annual gain. Short-term T-bill and fixed deposit yields have fallen below 1.5%, while 10-year government bonds hover near 2%. Lower yields are driving investors toward dividend stocks and REITs. Markets remain cautious ahead of the US Federal Reserve meeting this week.
Procter & Gamble (PG) Stock Hits Two‑Year Low as CFO Sounds Alarm on U.S. Consumer – What It Means for Investors Now

Procter & Gamble (PG) Stock Hits Two‑Year Low as CFO Sounds Alarm on U.S. Consumer – What It Means for Investors Now

Procter & Gamble shares fell to about $138 on December 9, 2025, down 23% from their 52-week high and near a two-year low after an analyst downgrade and cautious outlook from management. CFO Andre Schulten warned of a “more volatile” U.S. consumer environment, with significant declines in category volume and value in October and November.
9 Dezembro 2025
(OCUL) Stock Soars on Accelerated Wet AMD NDA – Price, Forecast & Risk Analysis as of December 9, 2025

(OCUL) Stock Soars on Accelerated Wet AMD NDA – Price, Forecast & Risk Analysis as of December 9, 2025

Ocular Therapeutix shares surged 28.1% to $16.11 on December 8, hitting a new 52-week high after the company announced plans to file an accelerated NDA for its retina drug AXPAXLI in wet AMD, based on a single Phase 3 trial. Trading volume spiked, and year-to-date gains reached about 44%. The company aims to submit the NDA after year-one SOL-1 trial data in Q1 2026.
9 Dezembro 2025
Warby Parker (WRBY) Soars on Google AI Glasses News: Is the Stock a Buy After December 2025’s Rally?

Warby Parker (WRBY) Soars on Google AI Glasses News: Is the Stock a Buy After December 2025’s Rally?

Warby Parker shares jumped over 13% to around $22 after Google confirmed their co-developed AI smart glasses will launch in 2026. The announcement, made at The Android Show, marks the first public timeline for the product. Google has committed up to $150 million to the partnership. Shares of rival EssilorLuxottica fell 4% as investors reacted to the news.
PepsiCo Stock Today: Elliott Deal, 2026 Outlook and Analyst Targets for PEP (December 9, 2025)

PepsiCo Stock Today: Elliott Deal, 2026 Outlook and Analyst Targets for PEP (December 9, 2025)

PepsiCo shares traded near $145.34 on December 9, 2025, after announcing a major cost-cutting and product simplification plan tied to a deal with Elliott Investment Management, which holds a $4 billion stake. The company will cut about 20% of U.S. product lines and introduce lower prices. Analysts raised price targets but remain cautious on near-term growth. Year-to-date, PepsiCo stock is down about 4%, trailing the S&P 500.
9 Dezembro 2025
Arcellx (ACLX) Stock Surges on Anito-cel Breakthrough Data as Analysts Boost Price Targets – December 9, 2025

Arcellx (ACLX) Stock Surges on Anito-cel Breakthrough Data as Analysts Boost Price Targets – December 9, 2025

Arcellx shares closed at $72.08 on December 9, down 2.7% after surging 13.6% pre-market on positive Phase 2 data for its multiple myeloma therapy anito-cel at ASH 2025. The iMMagine-1 study showed a 96% overall response rate and no delayed neurotoxicities in 117 heavily pretreated patients. Analysts maintain a “Strong Buy” consensus and anticipate a 2026 commercial launch.
Hawaiian Electric Industries (HE) Stock Soars on S&P 600 Inclusion – Latest News, Maui Settlement Update and 2026 Forecasts

Hawaiian Electric Industries (HE) Stock Soars on S&P 600 Inclusion – Latest News, Maui Settlement Update and 2026 Forecasts

Hawaiian Electric Industries stock surged over 11% on December 8, 2025, after S&P Dow Jones Indices announced its addition to the S&P SmallCap 600. Shares traded near $11.73 on December 9, with market cap at $2.1 billion. The move follows a year of legal pressure from Maui wildfire settlements, with analysts maintaining a “Hold” rating. Trading volume spiked to 1.4 million shares, well above normal levels.
SLM Stock Plunges Over 16% After Investor Day: New EPS Targets, Analyst Downgrades and 2026–2028 Outlook for Sallie Mae (SLM)

SLM Stock Plunges Over 16% After Investor Day: New EPS Targets, Analyst Downgrades and 2026–2028 Outlook for Sallie Mae (SLM)

SLM Corporation shares plunged 16–17% to about $25.85 on December 9 after its Investor Forum revealed sharply lower earnings guidance for 2026 and 2027. Management projected FY26 EPS of $2.63, about 23% below prior consensus, and signaled higher operating expenses tied to a strategic shift. Trading volume was several times normal. The stock now trades just above its 52-week low.
9 Dezembro 2025
MercadoLibre (MELI) Stock Today: Latest News, Q3 2025 Results, Analyst Forecasts and Outlook as of December 9, 2025

MercadoLibre (MELI) Stock Today: Latest News, Q3 2025 Results, Analyst Forecasts and Outlook as of December 9, 2025

MercadoLibre shares closed at $2,061 on December 9, 2025, down about 20% from a June peak but up over 20% for the year. The company posted its 27th straight quarter of 30%+ revenue growth, with Q3 net revenue up 39% to $7.4 billion. MercadoLibre issued $750 million in new bonds and will transition to a new CEO on January 1, 2026. Market cap stands near $105 billion.
9 Dezembro 2025
FCA Rips Up EU Investment Disclosure Rules in Landmark Post‑Brexit Shake‑Up: What It Means for UK Savers and Markets

FCA Rips Up EU Investment Disclosure Rules in Landmark Post‑Brexit Shake‑Up: What It Means for UK Savers and Markets

The UK Financial Conduct Authority has unveiled sweeping retail investment reforms, scrapping EU PRIIPs and UCITS disclosure rules in favor of a new Consumer Composite Investments regime. Wealthy individuals with over £10 million can opt out of retail protections under strict conditions. The new rules take effect from June 2027, with an optional transition starting April 2026.
9 Dezembro 2025
Walmart Stock (WMT) After Nasdaq Debut: Price Action, Analyst Upgrades and What to Watch Before the December 10, 2025 Open

Walmart Stock (WMT) After Nasdaq Debut: Price Action, Analyst Upgrades and What to Watch Before the December 10, 2025 Open

Walmart shares closed at $115.06 on December 9, 2025, its first day trading on the Nasdaq, just below a 52-week high of $116.27. Volume reached 22.5 million shares, about 20% above average. The company’s market cap stood near $900 billion, with a trailing P/E around 40. After hours, the stock held steady, with no major announcements.
10 Dezembro 2025
Eli Lilly’s $6 Billion Huntsville Plant: 450 High‑Paying Jobs, GLP‑1 Drug Boom and Alabama’s Biggest Industrial Bet

Eli Lilly’s $6 Billion Huntsville Plant: 450 High‑Paying Jobs, GLP‑1 Drug Boom and Alabama’s Biggest Industrial Bet

Eli Lilly will invest over $6 billion to build a pharmaceutical manufacturing campus in Huntsville, Alabama, creating 450 permanent and 3,000 construction jobs. The 260-acre facility will produce active ingredients for small-molecule and peptide medicines, including the oral GLP-1 obesity drug orforglipron. Construction is set to begin in 2026 and finish by 2032. State officials call it Alabama’s largest-ever private industrial investment.
10 Dezembro 2025
1 141 142 143 144 145 174
Go toTop